Article
Unveiling the Immunological Terrain of Pancreatic Ductal Adenocarcinoma: Strategies to Prompt Immunotherapy from Mendelian Randomization
2024-03-21
Abstract excerpt
<title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC) remains a formidable challenge in oncology, characterized by its immunosuppressive tumor microenvironment (TME) and resistance to immune checkpoint inhibitors (ICIs). This study leverages Mendelian randomization (MR) to elucidate the causal relationships between PDAC and a comprehensive array of immune cell traits, bacterial traits, inflammatory f...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fea353d7-1cdb-59ca-9196-fd83ec2f98bc
- DOI
- 10.21203/rs.3.rs-4000359/v1
